Showing results (851-860 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|April 8, 2014
Childhood and adolescent overweight and obesity in Latin America: a systematic reviewJuan Ángel Rivera, Teresita González de Cossío, Lilia Susana Pedraza, et al.
The Lancet. Diabetes & Endocrinology|May 6, 2014
Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trialUlrik Pedersen-Bjergaard, Peter Lommer Kristensen, Henning Beck-Nielsen, et al.
The Lancet. Diabetes & Endocrinology|May 6, 2014
Fatty kidney: emerging role of ectopic lipid in obesity-related renal diseaseAiko P J de Vries, Piero Ruggenenti, Xiong Z Ruan, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2014
The metabolic burden of sleep lossSebastian M Schmid, Manfred Hallschmid, Bernd Schultes
The Lancet. Diabetes & Endocrinology|April 16, 2014
The importance of dynamic signalling for endocrine regulation and drug development: relevance for glucocorticoid hormonesStafford Lightman, John R Terry
The Lancet. Diabetes & Endocrinology|April 16, 2014
Metabolic syndrome: a sympathetic disease?Markus Schlaich, Nora Straznicky, Elisabeth Lambert, et al.
The Lancet. Diabetes & Endocrinology|April 16, 2014
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trialMichaela Diamant, Luc Van Gaal, Bruno Guerci, et al.
The Lancet. Diabetes & Endocrinology|December 3, 2016
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation studyAmand F Schmidt, Daniel I Swerdlow, Michael V Holmes, et al.
The Lancet. Diabetes & Endocrinology|April 3, 2017
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trialsSophia Zoungas, Hisatomi Arima, Hertzel C Gerstein, et al.
The Lancet. Diabetes & Endocrinology|March 24, 2017
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trialJelena P Seferovic, Brian Claggett, Sara B Seidelmann, et al.
Pageof 93